S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
NASDAQ:PTRA

Proterra Stock Forecast, Price & News

$9.57
-0.20 (-2.05 %)
(As of 10/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.52
$9.79
50-Day Range
$8.96
$12.02
52-Week Range
$8.77
$31.06
Volume1.28 million shs
Average Volume2.10 million shs
Market Capitalization$2.03 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PTRA News and Ratings via Email

Sign-up to receive the latest news and ratings for Proterra and its competitors with MarketBeat's FREE daily newsletter.


Proterra logo

About Proterra

Proterra Inc is a developer and producer of commercial electric vehicle technology with an integrated business model focused on providing end-to-end solutions that enable commercial vehicle electrification through three main business units: Proterra Powered, Proterra Energy, and Proterra Transit.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Motor vehicles & car bodies
Sub-Industry
N/A
Current Symbol
NASDAQ:PTRA
Phone
N/A
Employees
709
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.14 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$2.03 billion
Next Earnings Date
11/10/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.94 out of 5 stars

Auto/Tires/Trucks Sector

64th out of 124 stocks

Motor Vehicles & Car Bodies Industry

17th out of 37 stocks

Analyst Opinion: 3.2Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Proterra (NASDAQ:PTRA) Frequently Asked Questions

Is Proterra a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Proterra in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Proterra stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PTRA, but not buy additional shares or sell existing shares.
View analyst ratings for Proterra
or view top-rated stocks.

What stocks does MarketBeat like better than Proterra?

Wall Street analysts have given Proterra a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Proterra wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Proterra's next earnings date?

Proterra is scheduled to release its next quarterly earnings announcement on Wednesday, November 10th 2021.
View our earnings forecast for Proterra
.

How were Proterra's earnings last quarter?

Proterra Inc. (NASDAQ:PTRA) announced its quarterly earnings results on Wednesday, August, 11th. The company reported ($1.33) earnings per share (EPS) for the quarter. The company earned $58.50 million during the quarter.
View Proterra's earnings history
.

How has Proterra's stock price been impacted by Coronavirus (COVID-19)?

Proterra's stock was trading at $0.0260 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PTRA stock has increased by 36,707.7% and is now trading at $9.57.
View which stocks have been most impacted by COVID-19
.

What guidance has Proterra issued on next quarter's earnings?

Proterra issued an update on its FY 2021 earnings guidance on Wednesday, September, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $246 million-$246 million.

What price target have analysts set for PTRA?

3 analysts have issued 12 month price objectives for Proterra's shares. Their forecasts range from $15.00 to $16.00. On average, they expect Proterra's stock price to reach $15.50 in the next twelve months. This suggests a possible upside of 62.0% from the stock's current price.
View analysts' price targets for Proterra
or view top-rated stocks among Wall Street analysts.

Who are Proterra's key executives?

Proterra's management team includes the following people:
  • John Mercadante, Chairman, President, CEO & CFO
  • Douglas Cerny, Director & Chief Development Officer

What is Proterra's stock symbol?

Proterra trades on the NASDAQ under the ticker symbol "PTRA."

Who are Proterra's major shareholders?

Proterra's stock is owned by many different retail and institutional investors. Top institutional shareholders include DNB Asset Management AS (0.04%), Carroll Financial Associates Inc. (0.02%) and Tarbox Family Office Inc. (0.00%).
View institutional ownership trends for Proterra
.

Which major investors are buying Proterra stock?

PTRA stock was acquired by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Carroll Financial Associates Inc., and Tarbox Family Office Inc..
View insider buying and selling activity for Proterra
or or view top insider-buying stocks.

How do I buy shares of Proterra?

Shares of PTRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Proterra's stock price today?

One share of PTRA stock can currently be purchased for approximately $9.57.

How much money does Proterra make?

Proterra has a market capitalization of $2.03 billion.

How many employees does Proterra have?

Proterra employs 709 workers across the globe.

What is Proterra's official website?

The official website for Proterra is www.proterra.com.

Where are Proterra's headquarters?

How can I contact Proterra?

Proterra's mailing address is 200 CLARENDON STREET 55TH FLOOR, BOSTON MA, 02116. The company can be reached via email at [email protected].


This page was last updated on 10/18/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.